|
Summary of the primers designed and used in the study. |
||||
| Gene |
Forward primer |
Reverse Primer |
Amplicon length |
mRNA location |
|
|
||||
| Human Prox1 (Exon 3–4) |
5'-GCT CCA ATA TGC TGA AGA CC-3' |
5'-ATC GTT GAT GGC TTG ACG TG-3' |
120 bp |
2399–2519 |
| Human HNF4α |
5'-GGG GTA CCC ATG GCC GAC TAC AGT G-3' |
5'-GGG GTA CCG CGC TGA CAC CCA GGC TG-3' |
140 bp |
122 – 262 |
| Human albumin |
5'-CTG TGG GGC ACT TTT GAA AT-3' |
5'-AAC ATC CCC TTC ACA GCA TC-3' |
154 bp |
698 – 851 |
| Human CREB |
5'-GAC ACC AGC TGG AGA AGG AC-3' |
5'-CTT CTT GGT GTC CCA TGC TT-3' |
198 bp |
500 – 698 |
| Human AP-4 |
5'-GTG CCC TCT TTG CAA CAT TT-3' |
5'-CTG CCT TGC TGA GCT TCT CT-3' |
229 bp |
289 – 517 |
| Human N-myc |
5'-GAC TGT AGC CAT CCG AGG AC-3' |
5'-GTT TTA ATA CCG GGG GTG CT-3' |
161 bp |
92 – 253 |
| Human MAZ |
5'-TAC CAC CTG AAC CGA CAC AA-3' |
5'-GCT GCC TCA CAT TTC TCA CA-3' |
247 bp |
1040 – 1287 |
Dudas et al. BMC Cancer 2008 8:92 doi:10.1186/1471-2407-8-92 |
||||